Global Cancer Anorexia-Cachexia Syndrome Drug Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Cancer Anorexia-Cachexia Syndrome Drug Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Cancer Anorexia-Cachexia Syndrome Drug by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Cancer Anorexia-Cachexia Syndrome Drug by Country/Region, 2017, 2022 & 2028

2.2 Cancer Anorexia-Cachexia Syndrome Drug Segment by Type

2.2.1 NEO-1940

2.2.2 C-1889

2.2.3 DLN-101

2.2.4 Foxo1-nRNA

2.2.5 AVGN-7

2.2.6 Others

2.3 Cancer Anorexia-Cachexia Syndrome Drug Sales by Type

2.3.1 Global Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Type (2017-2022)

2.3.2 Global Cancer Anorexia-Cachexia Syndrome Drug Revenue and Market Share by Type (2017-2022)

2.3.3 Global Cancer Anorexia-Cachexia Syndrome Drug Sale Price by Type (2017-2022)

2.4 Cancer Anorexia-Cachexia Syndrome Drug Segment by Application

2.4.1 Hospital

2.4.2 Clinic

2.4.3 Others

2.5 Cancer Anorexia-Cachexia Syndrome Drug Sales by Application

2.5.1 Global Cancer Anorexia-Cachexia Syndrome Drug Sale Market Share by Application (2017-2022)

2.5.2 Global Cancer Anorexia-Cachexia Syndrome Drug Revenue and Market Share by Application (2017-2022)

2.5.3 Global Cancer Anorexia-Cachexia Syndrome Drug Sale Price by Application (2017-2022)

3 Global Cancer Anorexia-Cachexia Syndrome Drug by Company

3.1 Global Cancer Anorexia-Cachexia Syndrome Drug Breakdown Data by Company

3.1.1 Global Cancer Anorexia-Cachexia Syndrome Drug Annual Sales by Company (2020-2022)

3.1.2 Global Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Company (2020-2022)

3.2 Global Cancer Anorexia-Cachexia Syndrome Drug Annual Revenue by Company (2020-2022)

3.2.1 Global Cancer Anorexia-Cachexia Syndrome Drug Revenue by Company (2020-2022)

3.2.2 Global Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share by Company (2020-2022)

3.3 Global Cancer Anorexia-Cachexia Syndrome Drug Sale Price by Company

3.4 Key Manufacturers Cancer Anorexia-Cachexia Syndrome Drug Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Cancer Anorexia-Cachexia Syndrome Drug Product Location Distribution

3.4.2 Players Cancer Anorexia-Cachexia Syndrome Drug Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Cancer Anorexia-Cachexia Syndrome Drug by Geographic Region

4.1 World Historic Cancer Anorexia-Cachexia Syndrome Drug Market Size by Geographic Region (2017-2022)

4.1.1 Global Cancer Anorexia-Cachexia Syndrome Drug Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Cancer Anorexia-Cachexia Syndrome Drug Annual Revenue by Geographic Region

4.2 World Historic Cancer Anorexia-Cachexia Syndrome Drug Market Size by Country/Region (2017-2022)

4.2.1 Global Cancer Anorexia-Cachexia Syndrome Drug Annual Sales by Country/Region (2017-2022)

4.2.2 Global Cancer Anorexia-Cachexia Syndrome Drug Annual Revenue by Country/Region

4.3 Americas Cancer Anorexia-Cachexia Syndrome Drug Sales Growth

4.4 APAC Cancer Anorexia-Cachexia Syndrome Drug Sales Growth

4.5 Europe Cancer Anorexia-Cachexia Syndrome Drug Sales Growth

4.6 Middle East & Africa Cancer Anorexia-Cachexia Syndrome Drug Sales Growth

5 Americas

5.1 Americas Cancer Anorexia-Cachexia Syndrome Drug Sales by Country

5.1.1 Americas Cancer Anorexia-Cachexia Syndrome Drug Sales by Country (2017-2022)

5.1.2 Americas Cancer Anorexia-Cachexia Syndrome Drug Revenue by Country (2017-2022)

5.2 Americas Cancer Anorexia-Cachexia Syndrome Drug Sales by Type

5.3 Americas Cancer Anorexia-Cachexia Syndrome Drug Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Cancer Anorexia-Cachexia Syndrome Drug Sales by Region

6.1.1 APAC Cancer Anorexia-Cachexia Syndrome Drug Sales by Region (2017-2022)

6.1.2 APAC Cancer Anorexia-Cachexia Syndrome Drug Revenue by Region (2017-2022)

6.2 APAC Cancer Anorexia-Cachexia Syndrome Drug Sales by Type

6.3 APAC Cancer Anorexia-Cachexia Syndrome Drug Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Cancer Anorexia-Cachexia Syndrome Drug by Country

7.1.1 Europe Cancer Anorexia-Cachexia Syndrome Drug Sales by Country (2017-2022)

7.1.2 Europe Cancer Anorexia-Cachexia Syndrome Drug Revenue by Country (2017-2022)

7.2 Europe Cancer Anorexia-Cachexia Syndrome Drug Sales by Type

7.3 Europe Cancer Anorexia-Cachexia Syndrome Drug Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Cancer Anorexia-Cachexia Syndrome Drug by Country

8.1.1 Middle East & Africa Cancer Anorexia-Cachexia Syndrome Drug Sales by Country (2017-2022)

8.1.2 Middle East & Africa Cancer Anorexia-Cachexia Syndrome Drug Revenue by Country (2017-2022)

8.2 Middle East & Africa Cancer Anorexia-Cachexia Syndrome Drug Sales by Type

8.3 Middle East & Africa Cancer Anorexia-Cachexia Syndrome Drug Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Cancer Anorexia-Cachexia Syndrome Drug

10.3 Manufacturing Process Analysis of Cancer Anorexia-Cachexia Syndrome Drug

10.4 Industry Chain Structure of Cancer Anorexia-Cachexia Syndrome Drug

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Cancer Anorexia-Cachexia Syndrome Drug Distributors

11.3 Cancer Anorexia-Cachexia Syndrome Drug Customer

12 World Forecast Review for Cancer Anorexia-Cachexia Syndrome Drug by Geographic Region

12.1 Global Cancer Anorexia-Cachexia Syndrome Drug Market Size Forecast by Region

12.1.1 Global Cancer Anorexia-Cachexia Syndrome Drug Forecast by Region (2023-2028)

12.1.2 Global Cancer Anorexia-Cachexia Syndrome Drug Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Cancer Anorexia-Cachexia Syndrome Drug Forecast by Type

12.7 Global Cancer Anorexia-Cachexia Syndrome Drug Forecast by Application

13 Key Players Analysis

13.1 Acacia Pharma Ltd

13.1.1 Acacia Pharma Ltd Company Information

13.1.2 Acacia Pharma Ltd Cancer Anorexia-Cachexia Syndrome Drug Product Offered

13.1.3 Acacia Pharma Ltd Cancer Anorexia-Cachexia Syndrome Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Acacia Pharma Ltd Main Business Overview

13.1.5 Acacia Pharma Ltd Latest Developments

13.2 Aeterna Zentaris Inc

13.2.1 Aeterna Zentaris Inc Company Information

13.2.2 Aeterna Zentaris Inc Cancer Anorexia-Cachexia Syndrome Drug Product Offered

13.2.3 Aeterna Zentaris Inc Cancer Anorexia-Cachexia Syndrome Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Aeterna Zentaris Inc Main Business Overview

13.2.5 Aeterna Zentaris Inc Latest Developments

13.3 Aphios Corp

13.3.1 Aphios Corp Company Information

13.3.2 Aphios Corp Cancer Anorexia-Cachexia Syndrome Drug Product Offered

13.3.3 Aphios Corp Cancer Anorexia-Cachexia Syndrome Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Aphios Corp Main Business Overview

13.3.5 Aphios Corp Latest Developments

13.4 Incyte Corp

13.4.1 Incyte Corp Company Information

13.4.2 Incyte Corp Cancer Anorexia-Cachexia Syndrome Drug Product Offered

13.4.3 Incyte Corp Cancer Anorexia-Cachexia Syndrome Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Incyte Corp Main Business Overview

13.4.5 Incyte Corp Latest Developments

13.5 Lakewood-Amedex Inc

13.5.1 Lakewood-Amedex Inc Company Information

13.5.2 Lakewood-Amedex Inc Cancer Anorexia-Cachexia Syndrome Drug Product Offered

13.5.3 Lakewood-Amedex Inc Cancer Anorexia-Cachexia Syndrome Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Lakewood-Amedex Inc Main Business Overview

13.5.5 Lakewood-Amedex Inc Latest Developments

13.6 Novartis AG

13.6.1 Novartis AG Company Information

13.6.2 Novartis AG Cancer Anorexia-Cachexia Syndrome Drug Product Offered

13.6.3 Novartis AG Cancer Anorexia-Cachexia Syndrome Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Novartis AG Main Business Overview

13.6.5 Novartis AG Latest Developments

13.7 Obexia AG

13.7.1 Obexia AG Company Information

13.7.2 Obexia AG Cancer Anorexia-Cachexia Syndrome Drug Product Offered

13.7.3 Obexia AG Cancer Anorexia-Cachexia Syndrome Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Obexia AG Main Business Overview

13.7.5 Obexia AG Latest Developments

13.8 PsiOxus Therapeutics Ltd

13.8.1 PsiOxus Therapeutics Ltd Company Information

13.8.2 PsiOxus Therapeutics Ltd Cancer Anorexia-Cachexia Syndrome Drug Product Offered

13.8.3 PsiOxus Therapeutics Ltd Cancer Anorexia-Cachexia Syndrome Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 PsiOxus Therapeutics Ltd Main Business Overview

13.8.5 PsiOxus Therapeutics Ltd Latest Developments

13.9 RaQualia Pharma Inc

13.9.1 RaQualia Pharma Inc Company Information

13.9.2 RaQualia Pharma Inc Cancer Anorexia-Cachexia Syndrome Drug Product Offered

13.9.3 RaQualia Pharma Inc Cancer Anorexia-Cachexia Syndrome Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 RaQualia Pharma Inc Main Business Overview

13.9.5 RaQualia Pharma Inc Latest Developments

13.10 Viking Therapeutics Inc

13.10.1 Viking Therapeutics Inc Company Information

13.10.2 Viking Therapeutics Inc Cancer Anorexia-Cachexia Syndrome Drug Product Offered

13.10.3 Viking Therapeutics Inc Cancer Anorexia-Cachexia Syndrome Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Viking Therapeutics Inc Main Business Overview

13.10.5 Viking Therapeutics Inc Latest Developments

14 Research Findings and Conclusion

Table 1. Cancer Anorexia-Cachexia Syndrome Drug Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Cancer Anorexia-Cachexia Syndrome Drug Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of NEO-1940

Table 4. Major Players of C-1889

Table 5. Major Players of DLN-101

Table 6. Major Players of Foxo1-nRNA

Table 7. Major Players of AVGN-7

Table 8. Major Players of Others

Table 9. Global Cancer Anorexia-Cachexia Syndrome Drug Sales by Type (2017-2022) & (K Pcs)

Table 10. Global Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Type (2017-2022)

Table 11. Global Cancer Anorexia-Cachexia Syndrome Drug Revenue by Type (2017-2022) & ($ million)

Table 12. Global Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share by Type (2017-2022)

Table 13. Global Cancer Anorexia-Cachexia Syndrome Drug Sale Price by Type (2017-2022) & (USD/Pcs)

Table 14. Global Cancer Anorexia-Cachexia Syndrome Drug Sales by Application (2017-2022) & (K Pcs)

Table 15. Global Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Application (2017-2022)

Table 16. Global Cancer Anorexia-Cachexia Syndrome Drug Revenue by Application (2017-2022)

Table 17. Global Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share by Application (2017-2022)

Table 18. Global Cancer Anorexia-Cachexia Syndrome Drug Sale Price by Application (2017-2022) & (USD/Pcs)

Table 19. Global Cancer Anorexia-Cachexia Syndrome Drug Sales by Company (2020-2022) & (K Pcs)

Table 20. Global Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Company (2020-2022)

Table 21. Global Cancer Anorexia-Cachexia Syndrome Drug Revenue by Company (2020-2022) ($ Millions)

Table 22. Global Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share by Company (2020-2022)

Table 23. Global Cancer Anorexia-Cachexia Syndrome Drug Sale Price by Company (2020-2022) & (USD/Pcs)

Table 24. Key Manufacturers Cancer Anorexia-Cachexia Syndrome Drug Producing Area Distribution and Sales Area

Table 25. Players Cancer Anorexia-Cachexia Syndrome Drug Products Offered

Table 26. Cancer Anorexia-Cachexia Syndrome Drug Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 27. New Products and Potential Entrants

Table 28. Mergers & Acquisitions, Expansion

Table 29. Global Cancer Anorexia-Cachexia Syndrome Drug Sales by Geographic Region (2017-2022) & (K Pcs)

Table 30. Global Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share Geographic Region (2017-2022)

Table 31. Global Cancer Anorexia-Cachexia Syndrome Drug Revenue by Geographic Region (2017-2022) & ($ millions)

Table 32. Global Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share by Geographic Region (2017-2022)

Table 33. Global Cancer Anorexia-Cachexia Syndrome Drug Sales by Country/Region (2017-2022) & (K Pcs)

Table 34. Global Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Country/Region (2017-2022)

Table 35. Global Cancer Anorexia-Cachexia Syndrome Drug Revenue by Country/Region (2017-2022) & ($ millions)

Table 36. Global Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share by Country/Region (2017-2022)

Table 37. Americas Cancer Anorexia-Cachexia Syndrome Drug Sales by Country (2017-2022) & (K Pcs)

Table 38. Americas Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Country (2017-2022)

Table 39. Americas Cancer Anorexia-Cachexia Syndrome Drug Revenue by Country (2017-2022) & ($ Millions)

Table 40. Americas Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share by Country (2017-2022)

Table 41. Americas Cancer Anorexia-Cachexia Syndrome Drug Sales by Type (2017-2022) & (K Pcs)

Table 42. Americas Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Type (2017-2022)

Table 43. Americas Cancer Anorexia-Cachexia Syndrome Drug Sales by Application (2017-2022) & (K Pcs)

Table 44. Americas Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Application (2017-2022)

Table 45. APAC Cancer Anorexia-Cachexia Syndrome Drug Sales by Region (2017-2022) & (K Pcs)

Table 46. APAC Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Region (2017-2022)

Table 47. APAC Cancer Anorexia-Cachexia Syndrome Drug Revenue by Region (2017-2022) & ($ Millions)

Table 48. APAC Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share by Region (2017-2022)

Table 49. APAC Cancer Anorexia-Cachexia Syndrome Drug Sales by Type (2017-2022) & (K Pcs)

Table 50. APAC Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Type (2017-2022)

Table 51. APAC Cancer Anorexia-Cachexia Syndrome Drug Sales by Application (2017-2022) & (K Pcs)

Table 52. APAC Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Application (2017-2022)

Table 53. Europe Cancer Anorexia-Cachexia Syndrome Drug Sales by Country (2017-2022) & (K Pcs)

Table 54. Europe Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Country (2017-2022)

Table 55. Europe Cancer Anorexia-Cachexia Syndrome Drug Revenue by Country (2017-2022) & ($ Millions)

Table 56. Europe Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share by Country (2017-2022)

Table 57. Europe Cancer Anorexia-Cachexia Syndrome Drug Sales by Type (2017-2022) & (K Pcs)

Table 58. Europe Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Type (2017-2022)

Table 59. Europe Cancer Anorexia-Cachexia Syndrome Drug Sales by Application (2017-2022) & (K Pcs)

Table 60. Europe Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Application (2017-2022)

Table 61. Middle East & Africa Cancer Anorexia-Cachexia Syndrome Drug Sales by Country (2017-2022) & (K Pcs)

Table 62. Middle East & Africa Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Country (2017-2022)

Table 63. Middle East & Africa Cancer Anorexia-Cachexia Syndrome Drug Revenue by Country (2017-2022) & ($ Millions)

Table 64. Middle East & Africa Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share by Country (2017-2022)

Table 65. Middle East & Africa Cancer Anorexia-Cachexia Syndrome Drug Sales by Type (2017-2022) & (K Pcs)

Table 66. Middle East & Africa Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Type (2017-2022)

Table 67. Middle East & Africa Cancer Anorexia-Cachexia Syndrome Drug Sales by Application (2017-2022) & (K Pcs)

Table 68. Middle East & Africa Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Application (2017-2022)

Table 69. Key Market Drivers & Growth Opportunities of Cancer Anorexia-Cachexia Syndrome Drug

Table 70. Key Market Challenges & Risks of Cancer Anorexia-Cachexia Syndrome Drug

Table 71. Key Industry Trends of Cancer Anorexia-Cachexia Syndrome Drug

Table 72. Cancer Anorexia-Cachexia Syndrome Drug Raw Material

Table 73. Key Suppliers of Raw Materials

Table 74. Cancer Anorexia-Cachexia Syndrome Drug Distributors List

Table 75. Cancer Anorexia-Cachexia Syndrome Drug Customer List

Table 76. Global Cancer Anorexia-Cachexia Syndrome Drug Sales Forecast by Region (2023-2028) & (K Pcs)

Table 77. Global Cancer Anorexia-Cachexia Syndrome Drug Sales Market Forecast by Region

Table 78. Global Cancer Anorexia-Cachexia Syndrome Drug Revenue Forecast by Region (2023-2028) & ($ millions)

Table 79. Global Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share Forecast by Region (2023-2028)

Table 80. Americas Cancer Anorexia-Cachexia Syndrome Drug Sales Forecast by Country (2023-2028) & (K Pcs)

Table 81. Americas Cancer Anorexia-Cachexia Syndrome Drug Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. APAC Cancer Anorexia-Cachexia Syndrome Drug Sales Forecast by Region (2023-2028) & (K Pcs)

Table 83. APAC Cancer Anorexia-Cachexia Syndrome Drug Revenue Forecast by Region (2023-2028) & ($ millions)

Table 84. Europe Cancer Anorexia-Cachexia Syndrome Drug Sales Forecast by Country (2023-2028) & (K Pcs)

Table 85. Europe Cancer Anorexia-Cachexia Syndrome Drug Revenue Forecast by Country (2023-2028) & ($ millions)

Table 86. Middle East & Africa Cancer Anorexia-Cachexia Syndrome Drug Sales Forecast by Country (2023-2028) & (K Pcs)

Table 87. Middle East & Africa Cancer Anorexia-Cachexia Syndrome Drug Revenue Forecast by Country (2023-2028) & ($ millions)

Table 88. Global Cancer Anorexia-Cachexia Syndrome Drug Sales Forecast by Type (2023-2028) & (K Pcs)

Table 89. Global Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share Forecast by Type (2023-2028)

Table 90. Global Cancer Anorexia-Cachexia Syndrome Drug Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 91. Global Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share Forecast by Type (2023-2028)

Table 92. Global Cancer Anorexia-Cachexia Syndrome Drug Sales Forecast by Application (2023-2028) & (K Pcs)

Table 93. Global Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share Forecast by Application (2023-2028)

Table 94. Global Cancer Anorexia-Cachexia Syndrome Drug Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 95. Global Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share Forecast by Application (2023-2028)

Table 96. Acacia Pharma Ltd Basic Information, Cancer Anorexia-Cachexia Syndrome Drug Manufacturing Base, Sales Area and Its Competitors

Table 97. Acacia Pharma Ltd Cancer Anorexia-Cachexia Syndrome Drug Product Offered

Table 98. Acacia Pharma Ltd Cancer Anorexia-Cachexia Syndrome Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 99. Acacia Pharma Ltd Main Business

Table 100. Acacia Pharma Ltd Latest Developments

Table 101. Aeterna Zentaris Inc Basic Information, Cancer Anorexia-Cachexia Syndrome Drug Manufacturing Base, Sales Area and Its Competitors

Table 102. Aeterna Zentaris Inc Cancer Anorexia-Cachexia Syndrome Drug Product Offered

Table 103. Aeterna Zentaris Inc Cancer Anorexia-Cachexia Syndrome Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 104. Aeterna Zentaris Inc Main Business

Table 105. Aeterna Zentaris Inc Latest Developments

Table 106. Aphios Corp Basic Information, Cancer Anorexia-Cachexia Syndrome Drug Manufacturing Base, Sales Area and Its Competitors

Table 107. Aphios Corp Cancer Anorexia-Cachexia Syndrome Drug Product Offered

Table 108. Aphios Corp Cancer Anorexia-Cachexia Syndrome Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 109. Aphios Corp Main Business

Table 110. Aphios Corp Latest Developments

Table 111. Incyte Corp Basic Information, Cancer Anorexia-Cachexia Syndrome Drug Manufacturing Base, Sales Area and Its Competitors

Table 112. Incyte Corp Cancer Anorexia-Cachexia Syndrome Drug Product Offered

Table 113. Incyte Corp Cancer Anorexia-Cachexia Syndrome Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 114. Incyte Corp Main Business

Table 115. Incyte Corp Latest Developments

Table 116. Lakewood-Amedex Inc Basic Information, Cancer Anorexia-Cachexia Syndrome Drug Manufacturing Base, Sales Area and Its Competitors

Table 117. Lakewood-Amedex Inc Cancer Anorexia-Cachexia Syndrome Drug Product Offered

Table 118. Lakewood-Amedex Inc Cancer Anorexia-Cachexia Syndrome Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 119. Lakewood-Amedex Inc Main Business

Table 120. Lakewood-Amedex Inc Latest Developments

Table 121. Novartis AG Basic Information, Cancer Anorexia-Cachexia Syndrome Drug Manufacturing Base, Sales Area and Its Competitors

Table 122. Novartis AG Cancer Anorexia-Cachexia Syndrome Drug Product Offered

Table 123. Novartis AG Cancer Anorexia-Cachexia Syndrome Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 124. Novartis AG Main Business

Table 125. Novartis AG Latest Developments

Table 126. Obexia AG Basic Information, Cancer Anorexia-Cachexia Syndrome Drug Manufacturing Base, Sales Area and Its Competitors

Table 127. Obexia AG Cancer Anorexia-Cachexia Syndrome Drug Product Offered

Table 128. Obexia AG Cancer Anorexia-Cachexia Syndrome Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 129. Obexia AG Main Business

Table 130. Obexia AG Latest Developments

Table 131. PsiOxus Therapeutics Ltd Basic Information, Cancer Anorexia-Cachexia Syndrome Drug Manufacturing Base, Sales Area and Its Competitors

Table 132. PsiOxus Therapeutics Ltd Cancer Anorexia-Cachexia Syndrome Drug Product Offered

Table 133. PsiOxus Therapeutics Ltd Cancer Anorexia-Cachexia Syndrome Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 134. PsiOxus Therapeutics Ltd Main Business

Table 135. PsiOxus Therapeutics Ltd Latest Developments

Table 136. RaQualia Pharma Inc Basic Information, Cancer Anorexia-Cachexia Syndrome Drug Manufacturing Base, Sales Area and Its Competitors

Table 137. RaQualia Pharma Inc Cancer Anorexia-Cachexia Syndrome Drug Product Offered

Table 138. RaQualia Pharma Inc Cancer Anorexia-Cachexia Syndrome Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 139. RaQualia Pharma Inc Main Business

Table 140. RaQualia Pharma Inc Latest Developments

Table 141. Viking Therapeutics Inc Basic Information, Cancer Anorexia-Cachexia Syndrome Drug Manufacturing Base, Sales Area and Its Competitors

Table 142. Viking Therapeutics Inc Cancer Anorexia-Cachexia Syndrome Drug Product Offered

Table 143. Viking Therapeutics Inc Cancer Anorexia-Cachexia Syndrome Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 144. Viking Therapeutics Inc Main Business

Table 145. Viking Therapeutics Inc Latest Developments

List of Figures

Figure 1. Picture of Cancer Anorexia-Cachexia Syndrome Drug

Figure 2. Cancer Anorexia-Cachexia Syndrome Drug Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Cancer Anorexia-Cachexia Syndrome Drug Sales Growth Rate 2017-2028 (K Pcs)

Figure 7. Global Cancer Anorexia-Cachexia Syndrome Drug Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Cancer Anorexia-Cachexia Syndrome Drug Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of NEO-1940

Figure 10. Product Picture of C-1889

Figure 11. Product Picture of DLN-101

Figure 12. Product Picture of Foxo1-nRNA

Figure 13. Product Picture of AVGN-7

Figure 14. Product Picture of Others

Figure 15. Global Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Type in 2021

Figure 16. Global Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share by Type (2017-2022)

Figure 17. Cancer Anorexia-Cachexia Syndrome Drug Consumed in Hospital

Figure 18. Global Cancer Anorexia-Cachexia Syndrome Drug Market: Hospital (2017-2022) & (K Pcs)

Figure 19. Cancer Anorexia-Cachexia Syndrome Drug Consumed in Clinic

Figure 20. Global Cancer Anorexia-Cachexia Syndrome Drug Market: Clinic (2017-2022) & (K Pcs)

Figure 21. Cancer Anorexia-Cachexia Syndrome Drug Consumed in Others

Figure 22. Global Cancer Anorexia-Cachexia Syndrome Drug Market: Others (2017-2022) & (K Pcs)

Figure 23. Global Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Application (2017-2022)

Figure 24. Global Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share by Application in 2021

Figure 25. Cancer Anorexia-Cachexia Syndrome Drug Revenue Market by Company in 2021 ($ Million)

Figure 26. Global Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share by Company in 2021

Figure 27. Global Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Geographic Region (2017-2022)

Figure 28. Global Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share by Geographic Region in 2021

Figure 29. Global Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Region (2017-2022)

Figure 30. Global Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share by Country/Region in 2021

Figure 31. Americas Cancer Anorexia-Cachexia Syndrome Drug Sales 2017-2022 (K Pcs)

Figure 32. Americas Cancer Anorexia-Cachexia Syndrome Drug Revenue 2017-2022 ($ Millions)

Figure 33. APAC Cancer Anorexia-Cachexia Syndrome Drug Sales 2017-2022 (K Pcs)

Figure 34. APAC Cancer Anorexia-Cachexia Syndrome Drug Revenue 2017-2022 ($ Millions)

Figure 35. Europe Cancer Anorexia-Cachexia Syndrome Drug Sales 2017-2022 (K Pcs)

Figure 36. Europe Cancer Anorexia-Cachexia Syndrome Drug Revenue 2017-2022 ($ Millions)

Figure 37. Middle East & Africa Cancer Anorexia-Cachexia Syndrome Drug Sales 2017-2022 (K Pcs)

Figure 38. Middle East & Africa Cancer Anorexia-Cachexia Syndrome Drug Revenue 2017-2022 ($ Millions)

Figure 39. Americas Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Country in 2021

Figure 40. Americas Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share by Country in 2021

Figure 41. United States Cancer Anorexia-Cachexia Syndrome Drug Revenue Growth 2017-2022 ($ Millions)

Figure 42. Canada Cancer Anorexia-Cachexia Syndrome Drug Revenue Growth 2017-2022 ($ Millions)

Figure 43. Mexico Cancer Anorexia-Cachexia Syndrome Drug Revenue Growth 2017-2022 ($ Millions)

Figure 44. Brazil Cancer Anorexia-Cachexia Syndrome Drug Revenue Growth 2017-2022 ($ Millions)

Figure 45. APAC Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Region in 2021

Figure 46. APAC Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share by Regions in 2021

Figure 47. China Cancer Anorexia-Cachexia Syndrome Drug Revenue Growth 2017-2022 ($ Millions)

Figure 48. Japan Cancer Anorexia-Cachexia Syndrome Drug Revenue Growth 2017-2022 ($ Millions)

Figure 49. South Korea Cancer Anorexia-Cachexia Syndrome Drug Revenue Growth 2017-2022 ($ Millions)

Figure 50. Southeast Asia Cancer Anorexia-Cachexia Syndrome Drug Revenue Growth 2017-2022 ($ Millions)

Figure 51. India Cancer Anorexia-Cachexia Syndrome Drug Revenue Growth 2017-2022 ($ Millions)

Figure 52. Australia Cancer Anorexia-Cachexia Syndrome Drug Revenue Growth 2017-2022 ($ Millions)

Figure 53. Europe Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Country in 2021

Figure 54. Europe Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share by Country in 2021

Figure 55. Germany Cancer Anorexia-Cachexia Syndrome Drug Revenue Growth 2017-2022 ($ Millions)

Figure 56. France Cancer Anorexia-Cachexia Syndrome Drug Revenue Growth 2017-2022 ($ Millions)

Figure 57. UK Cancer Anorexia-Cachexia Syndrome Drug Revenue Growth 2017-2022 ($ Millions)

Figure 58. Italy Cancer Anorexia-Cachexia Syndrome Drug Revenue Growth 2017-2022 ($ Millions)

Figure 59. Russia Cancer Anorexia-Cachexia Syndrome Drug Revenue Growth 2017-2022 ($ Millions)

Figure 60. Middle East & Africa Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Country in 2021

Figure 61. Middle East & Africa Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share by Country in 2021

Figure 62. Egypt Cancer Anorexia-Cachexia Syndrome Drug Revenue Growth 2017-2022 ($ Millions)

Figure 63. South Africa Cancer Anorexia-Cachexia Syndrome Drug Revenue Growth 2017-2022 ($ Millions)

Figure 64. Israel Cancer Anorexia-Cachexia Syndrome Drug Revenue Growth 2017-2022 ($ Millions)

Figure 65. Turkey Cancer Anorexia-Cachexia Syndrome Drug Revenue Growth 2017-2022 ($ Millions)

Figure 66. GCC Country Cancer Anorexia-Cachexia Syndrome Drug Revenue Growth 2017-2022 ($ Millions)

Figure 67. Manufacturing Cost Structure Analysis of Cancer Anorexia-Cachexia Syndrome Drug in 2021

Figure 68. Manufacturing Process Analysis of Cancer Anorexia-Cachexia Syndrome Drug

Figure 69. Industry Chain Structure of Cancer Anorexia-Cachexia Syndrome Drug

Figure 70. Channels of Distribution

Figure 71. Distributors Profiles